Key result
Potentially inappropriate prescribing affects ~55% of discharged older patients, driven by polypharmacy and hypertension.
Why the study?
Age-related pharmacokinetic and pharmacodynamic changes, multimorbidity, and polypharmacy can lead to inappropriate prescribing, warranting evaluation of potential inappropriate prescribings using explicit criteria.
What is the prevalence of potentially inappropriate prescribing according to STOPP-2 criteria and its associated risk factors among older patients discharged from an internal medicine department in Romania?
Cross-Sectional (n=417)
No
What is the prevalence of potentially inappropriate prescribing according to STOPP-2 criteria and its associated risk factors among older patients discharged from an internal medicine department in Romania?
Answers are grounded in this paper and cite their sources.
Over half of older patients discharged from an internal medicine department had potentially inappropriate prescriptions—most commonly antithrombotics in patients with high bleeding risk—highlighting the need for routine STOPP-2 medication reviews at discharge, especially in patients with hypertension, heart failure, and polypharmacy.
Pharmacokinetic and pharmacodynamic changes associated with old age, along with multimorbidity and polypharmacy might lead to inappropriate prescribing and adverse reactions. Explicit criteria such as the Screening tool of older people's prescribing (STOPP) are useful to identify potential inappropriate prescribing's (PIPs). Our retrospective study included discharge papers from patients aged ≥65 years, from an internal medicine department in Romania (January-June 2018). A subset of the STOPP-2 criteria was used to assess the prevalence and characteristics of PIPs. Regression analysis was performed to evaluate the impact of associated risk factors (i.e., age, gender, polypharmacy and specific disease). Out of the 516 discharge papers analyzed, 417 were further assessed for PIPs. Patients' mean age was 75 years, 61.63% were female and 55.16% had at least one PIP, with 81.30% having one or two PIPs. Antithrombotic agents in patients with significant bleeding risk was the most prevalent PIP (23.98%), followed by the use of benzodiazepines (9.11%). Polypharmacy, extreme (>10 drugs) polypharmacy, hypertension and congestive heart failure were found as independent risk factors. PIP was prevalent and increased with (extreme) polypharmacy and specific cardiac disease. Comprehensive criteria like STOPP should be regularly used in clinical practice to identify PIPs to prevent potential harm.
No takes yet. Share an insight, caveat, or question.
Sipos et al. (2023) conducted a cross-sectional in Older adults discharged from an internal medicine department (n=417). Discharge prescriptions evaluated by a 34-criteria subset of STOPP-2 (including polypharmacy, hypertension, and congestive heart failure as risk factors) vs. Patients without potentially inappropriate prescribing (non-PIP group) was evaluated on Prevalence of potentially inappropriate prescribing (PIP) at hospital discharge according to STOPP-2 criteria. Potentially inappropriate prescribing according to STOPP-2 criteria occurred in 55.16% of discharged older patients, with polypharmacy and hypertension as independent risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: